| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.09B | -1.0% |
| Cost of Revenue | $642.4M | -8.5% |
| Gross Profit | $452.4M | +12.0% |
| R&D Expense | $3.3M | +560.0% |
| SG&A Expense | $176.2M | +24.2% |
| Operating Income | $276.2M | +11.9% |
| Pre-tax Income | $276.2M | +11.9% |
| Income Tax | $70.8M | +13.8% |
| Net Income | $205.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | -84.1% |
| Accounts Receivable | $41.1M | -58.0% |
| Inventory | $107.1M | -24.2% |
| Current Assets | $172.3M | -39.9% |
| Total Assets | $932.9M | -0.1% |
| Current Liabilities | $91.1M | -68.7% |
| Total Liabilities | $216.2M | -47.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $389.4M | +80.1% |
| Capital Expenditures | $166.1M | -5.8% |
| Investing Cash Flow | -$166.1M | +1.7% |
| Financing Cash Flow | -$233.7M | -32.7% |
| Free Cash Flow | $223.3M | +458.4% |
| +11.2% |
| EPS (Basic) | $1.89 | +14.5% |
| EPS (Diluted) | $1.89 | +14.5% |
| Stockholders' Equity |
| $716.7M |
| +38.3% |